Insulin-like growth factor-binding protein-3 and breast cancer survival

International Journal of Cancer

Volumn 79, Issue 6, 1998, Pages 624-628

  Yu, He ^a   Levesque, Michael A ^b,c   Javad Khosravi, M ^d   Papanastasiou Diamandi, Anastasia ^d   Clark, Gary M ^e   Diamandis, Eleftherios P ^b,c  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Diagnostic Systems Laboratories   (Canada)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, ESTROGEN; S PHASE;

EID: 0031767316     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981218)79:6<624::AID-IJC12>3.0.CO;2-9     Document Type: Article

References (23)

1. BUCKBINDER, L., TALBOTT, R., VELASCO-MIGUEL, S., TAKENAKA, I., FAHA, B., SEIZINGER, B.R. and KLEY, N., Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature (Lond.), 377, 646-649 (1995).
2. CHEN, J.-Y, SHAO, Z.-M., SHEIKH, M.S., HUSSAIN, A., LEROITH, D., ROBERTS, C.T. and FONTANA, J.A., Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J. cell. Physiol., 158, 69-78 (1994).
3. CLEMMONS, D.R., CAMACHO-HUBNER, C., CORONADO, E. and OSBORNE, C.K., Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology, 127, 2679-2686 (1990).
4. COHEN, P., FIELDER, P.J., HASEGAWA, Y., FRISCH, H., GIUDICE, L.C. and ROSENFELD, R.G., Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol., 124, 74-85 (1991).
5. COHEN, P., GRAVES, H.C.B., PEEHL, D.M., KAMAREI, M., GUIDICE, L.C. and ROSENFELD, R.G., Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. clin. Endocrinol. Metab., 75, 1046-1053 (1992).
6. FIGUEROA, J.A. and YEE, D., The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res. Treat., 22, 81-90 (1992).
7. GUCEV, Z.S., OH, Y., KELLEY, K.M. and ROSENFELD, R.G., Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res., 56, 1545-1550 (1996).
8. JONES, J.I. and CLEMMONS, D.R., Insulin-like growth factors and their binding proteins: biological actions. Endocrinol. Rev., 16, 3-34 (1995).
9. LEROITH, D., WERNER, H., BEITNER-JOHNSON, D. and ROBERTS, C.T., JR., Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrinol. Rev., 16, 143-163 (1995).
10. LEVESQUE, M.A., YU, H., CLARK, G.M. and DIAMANDIS, E.P., ELISA- detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort. J. clin. Oncol. 16, 2641-2650 (1998).
11. NICKERSON, T., HUYNH, H. and POLLAK, M., Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 cells and has a role in the induction of apoptosis by the antiestrogen ICI 182,780. Proc. Amer. Assoc. Cancer Res., 38, 172 (1997).
12. OH, Y., MULLER, H.L., LAMSON, G. and ROSENFELD, R.G., Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J. biol. Chem., 268, 14964-14971 (1993).
13. OH, Y., MULLER, H.L., NG, L. and ROSENFELD, R.G., Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. biol. Chem., 270, 13589-13592 (1995).
14. PARRIZAS, M. and LEROITH, D., Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology, 138, 1355-1358 (1997).
15. PEKONEN, F., NYMAN, T., ILVESMAKI, V. and PARTANEN, S., Insulin-like growth factor binding proteins in human breast cancer tissue. Cancer Res., 52, 5204-5207 (1992).
16. PRATT, S.E. and POLLAK, M.N., Insulin-like growth factor-binding protein-3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem. biophys. Res. Comm., 198, 292-297 (1994).
17. ROCHA, R.L., HILSENBECK, S.G., JACKSON, J.G., LEE, A.V., FIGUEROA, J.A. and YEE, D., Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J. nat. Cancer Inst., 88, 601-606 (1996).
18. ROCHA, R.L., HILSENBECK, S.G., JACKSON, J.G., VANDENBERG, C.L., WENG, C., LEE, A.V. and YEE, D., Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin. Cancer Res., 3, 103-109 (1997).
19. SALAHIFAR, H., BAXTER, R.C. and MARTIN, J.L., Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction. Endocrinology, 138, 1683-1690 (1997).
20. SHEIKH, M.S., SHAO, Z.-M., CLEMMONS, D.R., LEROITH, D., ROBERTS, C.T., JR. and FONTANA, J.A., Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells. Biochem. biophys. Res. Comm., 183, 1003-1010 (1992).
21. YEE, D., SHARMA, J. and HILSENBECK, S.G., Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer. J. nat. Cancer Inst., 86, 1785-1789 (1994).
22. YU, H., LEVESQUE, M.A., CLARK, G.M. and DIAMANDIS, E.P, Prognostic value of prostate specific antigen for women with breast cancer - a large U.S. cohort study. Clin. Cancer Res., 4, 1489-1497 (1998).
23. YU, H., LEVESQUE, M.A., KHOSRAVI, M.J., PAPANASTASIOU-DIAMANDI, A., CLARK, G.M. and DIAMANDIS, E.P, Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. Brit. J. Cancer, 74, 1242-1247 (1996).